Search

Lei Yao

Examiner (ID: 12775, Phone: (571)272-3112 , Office: P/1642 )

Most Active Art Unit
1642
Art Unit(s)
1642
Total Applications
1328
Issued Applications
662
Pending Applications
127
Abandoned Applications
552

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 8963002 [patent_doc_number] => 20130202604 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-08-08 [patent_title] => 'Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor' [patent_app_type] => utility [patent_app_number] => 13/749180 [patent_app_country] => US [patent_app_date] => 2013-01-24 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 6 [patent_no_of_words] => 5870 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13749180 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/749180
Therapeutic Uses of Monoclonal Antibodies to the Angiotensin-II Type-1 Receptor Jan 23, 2013 Abandoned
Array ( [id] => 8916359 [patent_doc_number] => 20130177984 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-07-11 [patent_title] => 'Tumor Suppressor Gene, p28ING5' [patent_app_type] => utility [patent_app_number] => 13/747282 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 30173 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13747282 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/747282
Tumor Suppressor Gene, p28ING5 Jan 21, 2013 Abandoned
Array ( [id] => 10176271 [patent_doc_number] => 09206467 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-12-08 [patent_title] => 'Tyrosine kinome' [patent_app_type] => utility [patent_app_number] => 13/746376 [patent_app_country] => US [patent_app_date] => 2013-01-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 4 [patent_no_of_words] => 4919 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13746376 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/746376
Tyrosine kinome Jan 21, 2013 Issued
Array ( [id] => 16695535 [patent_doc_number] => 10946104 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2021-03-16 [patent_title] => Aberrant cell-restricted immunoglobulins provided with a toxic moiety [patent_app_type] => utility [patent_app_number] => 14/372094 [patent_app_country] => US [patent_app_date] => 2013-01-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 8 [patent_no_of_words] => 12127 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 62 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14372094 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/372094
Aberrant cell-restricted immunoglobulins provided with a toxic moiety Jan 10, 2013 Issued
Array ( [id] => 10498561 [patent_doc_number] => 09226951 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-01-05 [patent_title] => 'Anti-tumor fibrillar human serum albumin methods and compositions' [patent_app_type] => utility [patent_app_number] => 13/738856 [patent_app_country] => US [patent_app_date] => 2013-01-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 22 [patent_no_of_words] => 7743 [patent_no_of_claims] => 1 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 107 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13738856 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/738856
Anti-tumor fibrillar human serum albumin methods and compositions Jan 9, 2013 Issued
Array ( [id] => 9295520 [patent_doc_number] => 20140039154 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-06 [patent_title] => 'PROTEIN DISULFIDE ISOMERASE ASSAY METHOD FOR THE IN VITRO DIAGNOSIS OF COLORECTAL CANCER' [patent_app_type] => utility [patent_app_number] => 13/732521 [patent_app_country] => US [patent_app_date] => 2013-01-02 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 26977 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13732521 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/732521
Protein disulfide isomerase assay method for the in vitro diagnosis of colorectal cancer Jan 1, 2013 Issued
Array ( [id] => 10911742 [patent_doc_number] => 20140314758 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-23 [patent_title] => 'IMMUNOGENIC TUMOR ASSOCIATED STROMAL CELL ANTIGEN PEPTIDES AND METHODS OF THEIR USE' [patent_app_type] => utility [patent_app_number] => 14/358705 [patent_app_country] => US [patent_app_date] => 2012-11-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 45660 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14358705 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/358705
Immunogenic tumor associated stromal cell antigen peptides and methods of their use Nov 14, 2012 Issued
Array ( [id] => 10627643 [patent_doc_number] => 09345782 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2016-05-24 [patent_title] => 'Therapeutic agents and uses thereof' [patent_app_type] => utility [patent_app_number] => 14/354617 [patent_app_country] => US [patent_app_date] => 2012-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 46 [patent_figures_cnt] => 29 [patent_no_of_words] => 19053 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 95 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354617 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/354617
Therapeutic agents and uses thereof Oct 25, 2012 Issued
Array ( [id] => 10905287 [patent_doc_number] => 20140308301 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-16 [patent_title] => 'CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES' [patent_app_type] => utility [patent_app_number] => 14/354472 [patent_app_country] => US [patent_app_date] => 2012-10-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19222 [patent_no_of_claims] => 25 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14354472 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/354472
CD44 MONOCLONAL ANTIBODY FOR THE TREATMENT OF B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA AND OTHER HEMATOLOGICAL MALIGNANCIES Oct 25, 2012 Abandoned
Array ( [id] => 8865602 [patent_doc_number] => 20130149305 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-06-13 [patent_title] => 'SOLUBLE CD80 AS A THERAPEUTIC TO REVERSE IMMUNE SUPRESSION IN CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/660037 [patent_app_country] => US [patent_app_date] => 2012-10-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 11729 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13660037 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/660037
Soluble CD80 as a therapeutic to reverse immune supression in cancer patients Oct 24, 2012 Issued
Array ( [id] => 9306097 [patent_doc_number] => 20140044771 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-02-13 [patent_title] => 'ENZYME PRODRUG CANCER THERAPY SELECTIVELY TARGETED TO TUMOR VASCULATURE AND METHODS OF PRODUCTION AND USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/655913 [patent_app_country] => US [patent_app_date] => 2012-10-19 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 15557 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13655913 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/655913
Enzyme prodrug cancer therapy selectively targeted to tumor vasculature and methods of production and use thereof Oct 18, 2012 Issued
Array ( [id] => 8617284 [patent_doc_number] => 20130022596 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS' [patent_app_type] => utility [patent_app_number] => 13/630860 [patent_app_country] => US [patent_app_date] => 2012-09-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 17721 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13630860 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/630860
METHODS AND COMPOSITIONS FOR DIAGNOSTIC USE IN CANCER PATIENTS Sep 27, 2012 Abandoned
Array ( [id] => 10225904 [patent_doc_number] => 20150110897 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-04-23 [patent_title] => 'Sperm Protein as a Detection Biomarker of Early Stage Ovarian Cancer' [patent_app_type] => utility [patent_app_number] => 14/345208 [patent_app_country] => US [patent_app_date] => 2012-09-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 14691 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14345208 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/345208
Sperm Protein as a Detection Biomarker of Early Stage Ovarian Cancer Sep 11, 2012 Abandoned
Array ( [id] => 10919325 [patent_doc_number] => 20140322344 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-10-30 [patent_title] => 'VACCINE PREPARATION FOR CANCER TREATMENT' [patent_app_type] => utility [patent_app_number] => 14/241321 [patent_app_country] => US [patent_app_date] => 2012-08-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 7865 [patent_no_of_claims] => 27 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14241321 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/241321
VACCINE PREPARATION FOR CANCER TREATMENT Aug 29, 2012 Abandoned
Array ( [id] => 8710320 [patent_doc_number] => 20130067608 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'COLON CANCER TARGETS AND USES THEREOF' [patent_app_type] => utility [patent_app_number] => 13/587215 [patent_app_country] => US [patent_app_date] => 2012-08-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 66465 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13587215 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/587215
COLON CANCER TARGETS AND USES THEREOF Aug 15, 2012 Abandoned
Array ( [id] => 11738303 [patent_doc_number] => 09702879 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-07-11 [patent_title] => 'Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas' [patent_app_type] => utility [patent_app_number] => 14/237682 [patent_app_country] => US [patent_app_date] => 2012-08-08 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 16 [patent_no_of_words] => 28689 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 201 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14237682 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/237682
Methods and products for in vitro diagnosis, in vitro prognosis and the development of drugs against invasive carcinomas Aug 7, 2012 Issued
Array ( [id] => 11908265 [patent_doc_number] => 09777068 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-03 [patent_title] => 'Method for treating a GD2 positive cancer' [patent_app_type] => utility [patent_app_number] => 14/409161 [patent_app_country] => US [patent_app_date] => 2012-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 17 [patent_figures_cnt] => 17 [patent_no_of_words] => 22494 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 135 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14409161 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/409161
Method for treating a GD2 positive cancer Jul 30, 2012 Issued
Array ( [id] => 9074568 [patent_doc_number] => 08552146 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2013-10-08 [patent_title] => 'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides' [patent_app_type] => utility [patent_app_number] => 13/562250 [patent_app_country] => US [patent_app_date] => 2012-07-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 35 [patent_no_of_words] => 21532 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 53 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13562250 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/562250
Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides Jul 29, 2012 Issued
Array ( [id] => 9656266 [patent_doc_number] => 20140227271 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'SOMATIC MUTATIONS IN ATRX IN BRAIN CANCER' [patent_app_type] => utility [patent_app_number] => 14/129850 [patent_app_country] => US [patent_app_date] => 2012-06-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 4693 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14129850 [rel_patent_id] =>[rel_patent_doc_number] =>)
14/129850
Somatic mutations in ATRX in brain cancer Jun 27, 2012 Issued
Array ( [id] => 9970684 [patent_doc_number] => 09017688 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-28 [patent_title] => 'Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides' [patent_app_type] => utility [patent_app_number] => 13/535297 [patent_app_country] => US [patent_app_date] => 2012-06-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 26 [patent_figures_cnt] => 35 [patent_no_of_words] => 21538 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 137 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13535297 [rel_patent_id] =>[rel_patent_doc_number] =>)
13/535297
Peptide vaccines for cancers expressing MPHOSPH1 or DEPDC1 polypeptides Jun 26, 2012 Issued
Menu